|
Susan Kramer Dr.P.H. joined Anesiva and was appointed vice president preclinical development in April 2006.
Dr. Kramer joins Anesiva from BAS Medical where she was a co-founder and served as vice president of research and development from 2003 to 2006. She was instrumental in the initiation of the company’s preclinical and clinical programs and participated in the raising of Series A and B funds. Prior to BAS Medical Dr. Kramer worked at Genentech for 18 years in a number of roles of increasing management responsibility including director of product development senior director of bioanalytical technology and ultimately as senior director of development sciences operations and strategic planning. She served as project team leader for products Actimmune® and Raptiva®. She led numerous pharmacology subteams and served on several key committees including the Product Development Committee.
Prior to Genentech Dr. Kramer served as the director of Medical Laboratories in Montes Claros Minas Gerais Brazil as a Peace Corps Volunteer followed by a stint as head of the clinical virology laboratory at the UCSF Medical Center at the onset of the AIDS epidemic.
Dr. Kramer holds Dr.P.H. and M.P.H. degrees in Biomedical Sciences from the University of California Berkeley. | 